The U.S. Food and Drug Administration has approved the first test that can quickly identify whether bacteria in Staphylococcus aureus infections are methicillin resistant (MRSA) or methicillin susceptible (MSSA), according to an FDA news release.
The KeyPath MRSA/MSSA Blood Culture Test can determine whether bacteria are MRSA or MSSA within approximately five hours after any bacteria growth is first detected in the sample. In a clinical study of 1,116 blood samples at four major U.S. hospital centers, the test was 98.9 percent accurate for detecting MRSA and 99.4 percent accurate for detecting MSSA.
Related Articles on Infection Control:
Acceptability of Suction Canister Use on Multiple Patients: Q&A With Jan Davidson of AORN
4 Critical Questions to Answer Before Running Your Next High-Level Disinfection Cycle
HHS Secretary Sebelius Applauds Hospitals for Joining Infection Prevention Initiative
The KeyPath MRSA/MSSA Blood Culture Test can determine whether bacteria are MRSA or MSSA within approximately five hours after any bacteria growth is first detected in the sample. In a clinical study of 1,116 blood samples at four major U.S. hospital centers, the test was 98.9 percent accurate for detecting MRSA and 99.4 percent accurate for detecting MSSA.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Read the FDA release on its approval of a drug to distinguish MRSA and MSSA.Related Articles on Infection Control:
Acceptability of Suction Canister Use on Multiple Patients: Q&A With Jan Davidson of AORN
4 Critical Questions to Answer Before Running Your Next High-Level Disinfection Cycle
HHS Secretary Sebelius Applauds Hospitals for Joining Infection Prevention Initiative
